VFC's Stock House provides informational and reasearch-based coverage of numerous companies in various sectors. It's also an opinion-based website intended to provide a starting point of ideas, where investors can follow-up with their own DD. Do not Buy/Sell based solely on VFC's ideas or opinions. See full disclaimer.
Sunday, August 28, 2011
Subscribe to:
Post Comments (Atom)
That thing that most concerns me about stocks like Dendreon is the approval process of bringing a drug to market it can be a long drawn out process. Their can be no assurance that the drug will win approval from the FDA.
ReplyDelete